Nyheder & Indsigt

Q1080261_+Blå_Low.jpg

Q1080261_+Blå_Low.jpg

Hovedstadens
Bygningsentreprise A/S
sold to Pinerock Group

Hovedstadens
Bygningsentreprise A/S
sold to Pinerock Group

The Legal 500:
Mergers & Acquisitions
Country Comparative Guide 2026

The Legal 500:
Mergers & Acquisitions
Country Comparative Guide 2026

Webinar: Løngennemsigtighed
- Nyt lovforslag i ekstern høring

Webinar: Løngennemsigtighed
- Nyt lovforslag i ekstern høring

Mette Gahrn-Jensen
stopper i Mazanti-Andersen

Mette Gahrn-Jensen
stopper i Mazanti-Andersen

Alle |

Cases |

Insights |

Events |

04/03/2021

Mazanti-Andersen advises the sellers in KKR’s acquisition of equity stake in Nordic Bioscience

Læs mere

01/03/2021

Er du og din virksomhed klar til besøg fra Konkurrence- og Forbrugerstyrelsen – både på kontoret og i private hjem?

Læs mere

25/02/2021

Y-mAbs Therapeutics, Inc. closes its USD 115 million US Public Offering

Læs mere

11/02/2021

Mazanti-Andersen advises Evaxion Biotech as it closes its U.S. initial public offering of American Depositary Shares

Læs mere

29/01/2021

Mazanti-Andersen advises Nexcom A/S on its listing on Nasdaq First North stock exchange

Læs mere

27/01/2021

Mazanti-Andersen advises FTSE 250 listed Diploma PLC on its acquisition of Simonsen & Weel A/S

Læs mere

04/03/2021

Mazanti-Andersen advises the sellers in KKR’s acquisition of equity stake in Nordic Bioscience

Læs mere

01/03/2021

Er du og din virksomhed klar til besøg fra Konkurrence- og Forbrugerstyrelsen – både på kontoret og i private hjem?

Læs mere

25/02/2021

Y-mAbs Therapeutics, Inc. closes its USD 115 million US Public Offering

Læs mere

11/02/2021

Mazanti-Andersen advises Evaxion Biotech as it closes its U.S. initial public offering of American Depositary Shares

Læs mere

29/01/2021

Mazanti-Andersen advises Nexcom A/S on its listing on Nasdaq First North stock exchange

Læs mere

27/01/2021

Mazanti-Andersen advises FTSE 250 listed Diploma PLC on its acquisition of Simonsen & Weel A/S

Læs mere

35
36
37
38
39